|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Interest income | ||
| Loss on sale of available-for-sale investments | ||
| Change in fair value of convertible loan notes | ||
| Total other income (expense) | ||
| Net loss | ||
| Unrealized gain (loss) on available-for-sale investments | ||
| Comprehensive loss | ||
| Accretion of issuance costs on redeemable convertible preferred stock | ||
| Accrued dividends on redeemable convertible preferred stock | ||
| Net loss attributable to common stockholders | ||
| Weighted-average common shares outstanding—basic and diluted | ||
| Net loss per share attributable to common stockholders—basic and diluted |
Loading...
